These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 8614377)

  • 1. Prevention of indwelling central venous catheter sepsis.
    Daghistani D; Horn M; Rodriguez Z; Schoenike S; Toledano S
    Med Pediatr Oncol; 1996 Jun; 26(6):405-8. PubMed ID: 8614377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial.
    Garland JS; Alex CP; Henrickson KJ; McAuliffe TL; Maki DG
    Pediatrics; 2005 Aug; 116(2):e198-205. PubMed ID: 15995005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of heparin-coated central venous lines to prevent catheter-related bloodstream infection.
    Abdelkefi A; Achour W; Ben Othman T; Ladeb S; Torjman L; Lakhal A; Ben Hassen A; Hsairi M; Ben Abdeladhim A
    J Support Oncol; 2007 Jun; 5(6):273-8. PubMed ID: 17624052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial.
    Hanna H; Benjamin R; Chatzinikolaou I; Alakech B; Richardson D; Mansfield P; Dvorak T; Munsell MF; Darouiche R; Kantarjian H; Raad I
    J Clin Oncol; 2004 Aug; 22(15):3163-71. PubMed ID: 15284269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Removal of percutaneously inserted central venous catheters in neonates is associated with the occurrence of sepsis.
    van den Hoogen A; Brouwer MJ; Gerards LJ; Fleer A; Krediet TG
    Acta Paediatr; 2008 Sep; 97(9):1250-2. PubMed ID: 18477060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer.
    Cesaro S; Tridello G; Cavaliere M; Magagna L; Gavin P; Cusinato R; Zadra N; Franco Zanon G; Zanesco L; Carli M
    J Clin Oncol; 2009 Apr; 27(12):2059-65. PubMed ID: 19273702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusidic acid and heparin lock solution for the prevention of catheter-related bloodstream infections in critically ill neonates: a retrospective study and a prospective, randomized trial.
    Filippi L; Pezzati M; Di Amario S; Poggi C; Pecile P
    Pediatr Crit Care Med; 2007 Nov; 8(6):556-62. PubMed ID: 17914310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of neonatal late-onset sepsis associated with the removal of percutaneously inserted central venous catheters in preterm infants.
    Hemels MA; van den Hoogen A; Verboon-Maciolek MA; Fleer A; Krediet TG
    Pediatr Crit Care Med; 2011 Jul; 12(4):445-8. PubMed ID: 21263371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of intralumenal and antibiotic-lock of vancomycin on the rate of catheter removal in the patients with permanent hemodialysis catheters.
    Beigi AA; Khansoltani S; Masoudpour H; Atapour AA; Eshaghian A; Khademi EF
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):54-8. PubMed ID: 20061693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability and in vitro efficacy of antibiotic-heparin lock solutions potentially useful for treatment of central venous catheter-related sepsis.
    Droste JC; Jeraj HA; MacDonald A; Farrington K
    J Antimicrob Chemother; 2003 Apr; 51(4):849-55. PubMed ID: 12654743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing central venous catheter-related bloodstream infections in children with cancer.
    Horvath B; Norville R; Lee D; Hyde A; Gregurich M; Hockenberry M
    Oncol Nurs Forum; 2009 Mar; 36(2):232-8. PubMed ID: 19273413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of silver-impregnated with standard multi-lumen central venous catheters in critically ill patients.
    Kalfon P; de Vaumas C; Samba D; Boulet E; Lefrant JY; Eyraud D; Lherm T; Santoli F; Naija W; Riou B
    Crit Care Med; 2007 Apr; 35(4):1032-9. PubMed ID: 17334256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of antiseptic bonding to prevent central venous catheter-related infection and sepsis.
    Ciresi DL; Albrecht RM; Volkers PA; Scholten DJ
    Am Surg; 1996 Aug; 62(8):641-6. PubMed ID: 8712561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution.
    Betjes MG; van Agteren M
    Nephrol Dial Transplant; 2004 Jun; 19(6):1546-51. PubMed ID: 14993498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of heparinization in prolonging patency of arterial and central venous catheters in children: a randomized double-blind trial.
    de Neef M; Heijboer H; van Woensel JB; de Haan RJ
    Pediatr Hematol Oncol; 2002 Dec; 19(8):553-60. PubMed ID: 12487830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of catheter-related bloodstream infection in critically ill patients using a disinfectable, needle-free connector: a randomized controlled trial.
    Yébenes JC; Vidaur L; Serra-Prat M; Sirvent JM; Batlle J; Motje M; Bonet A; Palomar M
    Am J Infect Control; 2004 Aug; 32(5):291-5. PubMed ID: 15292895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, controlled trial of heparin versus placebo infusion to prolong the usability of peripherally placed percutaneous central venous catheters (PCVCs) in neonates: the HIP (Heparin Infusion for PCVC) study.
    Shah PS; Kalyn A; Satodia P; Dunn MS; Parvez B; Daneman A; Salem S; Glanc P; Ohlsson A; Shah V
    Pediatrics; 2007 Jan; 119(1):e284-91. PubMed ID: 17200252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contamination of central venous catheters in immunocompromised patients: a comparison between two different types of central venous catheters.
    Stoiser B; Kofler J; Staudinger T; Georgopoulos A; Lugauer S; Guggenbichler JP; Burgmann H; Frass M
    J Hosp Infect; 2002 Mar; 50(3):202-6. PubMed ID: 11886196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sepsis in children with malignant neoplasia, equipped with a Broviac-type venous catheter].
    Garaventa A; Castagnola E; Dallorso S; Dini G; Trucco D; Vianello O; Carrega G; Cuneo P; Buffa P; Magillo P
    Pediatr Med Chir; 1995; 17(2):147-50. PubMed ID: 7610079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical pilot study on repeated use of heparin, vancomycin, colimycine locked flush solution for central intravenous implanted catheter in oncology].
    Guillet P; La Scola B; Bagarry-Liegey D; Lorvellec K; Martin N; Nicoara A; Baciuchka M; Duffaud F; Carissimi P; Cohen P; Delorme J; Carle G; Braguer D; Quilichini F; Crevat A; Favre R
    Pathol Biol (Paris); 1997 Jun; 45(6):506-13. PubMed ID: 9309269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.